Half, congratulations. I give your post #26794, post of the year. That is the most relevant example of how the process works, and gives Dr Moro a better idea of how to approach the FDA. Nice job.
Those type of posts are what brings me here. I also used Vermillion a while back as an example of what could transpire, and its effect on the share price due to the "special" nature of Dr Moro's discovery, however, the story behind its approval is fascinating and inspiring.
We need 2 major things to happen that will help the share price: 1)A new licensee 2)FDA approval. Then IMO Dr Moro should initiate a reverse split and IMMEDIATELY get us on a "normal" stock exchange. Until then we are, and will continue to be someone's prey. The OTC and the Pinks are the wild west like I said earlier and there are no regulations being enforced.
It is such old hat here. Whenever Biocurex puts out a press release then Gold has to spin it or demean it. Engaging a biased anonymous poster without a medical degree is a lost cause and a complete waste of time, but correcting misinformation by that individual has some merit.
I strongly concur with Dr Moro and his scientific board that using the receptor of AFP is a way to cure cancer. The problem is you cannot patent the receptor, only methods to direct an antibody to the receptor or a way to attach a molecule to the receptor. That is the holy grail, but to reach the holy grail, you must correctly identify the location of these cancerous cells, and that is precisely what Dr Moro has proved in so many ways. He has a way to find the cancer no matter the location or the stage of the cancer. A universal marker has tremendous value, because if Dr Moro can use an effective molecule that will be directed specifically to the cancer ANYWHERE in the body it is present, and not destroy or attach itself to healthy cells, he has effectively found a cure. I believe recaf will be utilized in this manner, but he must seperately patent the method to locate, deliver, and attach an antibody to that receptor.
IMO when he delivers on his promise of revenue the share price will move, otherwise it is futile when you have millions of shares outstanding and manipulators that will stair step it lower. The good news is that this will happen, regardless of the naysayers and the manipulators. GLTA
